Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Thrombin inhibitors with improved selectivity from Servier

Sep. 27, 1996

Antiplatelet ketoprofen analogue from Fuji Chem.

Sep. 20, 1996

Bristol-Myers Squibb to acquire prostacyclin analogue for claudication

Sep. 20, 1996

New prostacyclins from Asahi Glass

Sep. 20, 1996

Anticoagulant for treating blood clots approved in Canada

Sep. 20, 1996

R&D in blood coauglation at Daiichi

Sep. 13, 1996

Review on gpIIb/IIIa antagonists for ischemic complications

Sep. 13, 1996

Antiplatelet agents reported by Lilly

Sep. 13, 1996

Promising phase I data reported for oral heparin

Sep. 13, 1996

First human trial for transgenic product

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...